Helogen
New York, United States
◆ Total Raised
$7.1M
◆ Stage
seed
◆ Location
New York, United States
◆ Founded
2022
◆ Team size
11-50
◆ Links
◆ About Helogen
Helogen is a New York-based space biotechnology and in-orbit manufacturing startup building automated lab hardware and robotic equipment for microgravity to synthesize advanced biomaterials for medical implants.
◆ What sets it apart
Helogen combines autonomous orbital lab hardware, real-time sequencing/analytics, and microgravity manufacturing into an end-to-end platform for regulatory-grade biomaterial production in space.
◆ Sectors
◆ Business
Modelhardware
CustomerBiotech, life sciences, and materials companies seeking microgravity-enabled R&D and manufacturing, plus partners pursuing medical and advanced-material applications
◆ Notable
- Acquired Vellon Space to expand into India’s space and biotechnology sectors
- Announced partnership with AgResearch to manufacture advanced materials in space
- Reportedly won NASA’s 2025 TechLeap Prize
- Planned multiple in-orbit manufacturing missions for October 2026
◆ Backing funds on Raise
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Helogen do?
Helogen is a New York-based space biotechnology and in-orbit manufacturing startup building automated lab hardware and robotic equipment for microgravity to synthesize advanced biomaterials for medical implants.
Where is Helogen based?
Helogen is based in New York, United States, founded in 2022.
How much has Helogen raised?
Helogen has raised $7.1M in tracked funding and is currently at the seed stage.
Who has invested in Helogen?
Investors in Helogen include One Way Ventures Fund III.